Can ensidipine really cure leukemia?
Enasidenib (Enasidenib) is a new type of leukemia treatment drug. Although it is effective in certain types of leukemia in some cases, especially acute myeloid leukemia (AML) has shown significant efficacy, but whether it can truly cure leukemia still requires more in-depth research and long-term clinical observation.
First of all, it is worth noting that AML is a highly heterogeneous disease, and the condition of different patients may vary. Although ensidipine has shown certain therapeutic effects on AML patients carrying specific IDH2 gene mutations, not all AML patients have this gene mutation. Therefore, ensidipine may not be an effective treatment option for patients without this mutation.

Secondly, even if the patient carries theIDH2 gene mutation, ensidipine cannot guarantee a complete cure for leukemia. Treatment goals for leukemia often include controlling the number of leukemia cells below detectable limits to maintain patient survival and quality of life. Ensidipine has been shown in clinical trials to reduce the number of leukemia cells and extend progression-free survival, but there is no evidence that it can completely eliminate all leukemia cells and make patients permanently free of leukemia.
In addition, leukemia treatment is often a long-term process, including the combination of chemotherapy, targeted therapy, hematopoietic stem cell transplantation and other treatment methods. Ensidipine is usually used as monotherapy rather than as primary curative treatment. Therefore, during the treatment of leukemia, doctors usually combine other treatments for comprehensive treatment based on the patient's specific situation to achieve the best therapeutic effect.
In summary, although ensidipine has shown certain therapeutic effects in some specific AML patients, there is still some uncertainty as to whether it can truly "cure" leukemia. Leukemia treatment is a complex process that requires comprehensive consideration of the patient's condition, treatment goals and treatment plan to achieve the best treatment effect.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)